Morgan Stanley’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $991M | Buy |
|
|||||
|
2025
Q2 | $915M | Buy |
|
|||||
|
2025
Q1 | $787M | Buy |
|
|||||
|
2024
Q4 | $668M | Sell |
|
|||||
|
2024
Q3 | $803M | Sell |
|
|||||
|
2024
Q2 | $790M | Buy |
|
|||||
|
2024
Q1 | $702M | Sell |
|
|||||
|
2023
Q4 | $1.43B | Buy |
|
|||||
|
2023
Q3 | $711M | Sell |
|
|||||
|
2023
Q2 | $733M | Buy |
|
|||||
|
2023
Q1 | $609M | Buy |
|
|||||
|
2022
Q4 | $589M | Buy |
|
|||||
|
2022
Q3 | $464M | Sell |
|
|||||
|
2022
Q2 | $541M | Buy |
|
|||||
|
2022
Q1 | $286M | Sell |
|
|||||
|
2021
Q4 | $305M | Buy |
|
|||||
|
2021
Q3 | $263M | Buy |
|
|||||
|
2021
Q2 | $270M | Buy |
|
|||||
|
2021
Q1 | $243M | Buy |
|
|||||
|
2020
Q4 | $265M | Buy |
|
|||||
|
2020
Q3 | $221M | Sell |
|
|||||
|
2020
Q2 | $235M | Sell |
|
|||||
|
2020
Q1 | $310M | Buy |
|
|||||
|
2019
Q4 | $264M | Buy |
|
|||||
|
2019
Q3 | $211M | Buy |
|
|||||
|
2019
Q2 | $220M | Sell |
|
|||||
|
2019
Q1 | $296M | Buy |
|
|||||
|
2018
Q4 | $248M | Sell |
|
|||||
|
2018
Q3 | $253M | Buy |
|
|||||
|
2018
Q2 | $219M | Sell |
|
|||||
|
2018
Q1 | $236M | Buy |
|
|||||
|
2017
Q4 | $220M | Buy |
|
|||||
|
2017
Q3 | $200M | Buy |
|
|||||
|
2017
Q2 | $153M | Sell |
|
|||||
|
2017
Q1 | $144M | Buy |
|
|||||
|
2016
Q4 | $132M | Sell |
|
|||||
|
2016
Q3 | $145M | Buy |
|
|||||
|
2016
Q2 | $147M | Sell |
|
|||||
|
2016
Q1 | $130M | Sell |
|
|||||
|
2015
Q4 | $157M | Sell |
|
|||||
|
2015
Q3 | $193M | Sell |
|
|||||
|
2015
Q2 | $219M | Buy |
|
|||||
|
2015
Q1 | $187M | Sell |
|
|||||
|
2014
Q4 | $192M | Buy |
|
|||||
|
2014
Q3 | $174M | Buy |
|
|||||
|
2014
Q2 | $154M | Sell |
|
|||||
|
2014
Q1 | $156M | Sell |
|
|||||
|
2013
Q4 | $174M | Buy |
|
|||||
|
2013
Q3 | $148M | Sell |
|
|||||
|
2013
Q2 | $272M | Buy |
|